Word

POSMADIGM

Status

Pending

Status Code

681

Status Date

Wednesday, April 3, 2024

Serial Number

79389837

Mark Type

4000

Filing Date

Friday, November 17, 2023

Trademark Owner History

NOVARTIS AG

Classifications

5 Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Trademark Events

Apr 1, 2024

Approved For Pub - Principal Register

Mar 15, 2024

Assigned To Examiner

Mar 8, 2024

Teas Change Of Correspondence Received

Mar 8, 2024

Teas Change Of Domestic Representatives Address

Mar 8, 2024

Attorney/Dom.Rep.Revoked And/Or Appointed

Mar 8, 2024

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Mar 8, 2024

Applicant/Correspondence Changes (Non-Responsive) Entered

Mar 8, 2024

Teas Change Of Owner Address Received

Mar 5, 2024

Application Filing Receipt Mailed

Feb 28, 2024

New Application Office Supplied Data Entered

Feb 27, 2024

Limitation From Original Application Entered

Feb 22, 2024

Sn Assigned For Sect 66a Appl From Ib